Series C - LifeMine Therapeutics - Mar 23, 2022 Funding Round Profile - Cointime

Bitcoin $95,073.15 -1.26%
Ethereum $3,576.08 -2.12%
BNB $657.18 +1.71%
Optimism $2.34 -1.69%
Arbitrum $0.91 -3.80%
Solana $236.01 -1.90%
Polygon $0.56 -2.46%
Cosmos $8.21 -0.29%
Avalanche $42.39 -2.83%

Bitcoin $95,073.15 -1.26%
Ethereum $3,576.08 -2.12%
BNB $657.18 +1.71%
Optimism $2.34 -1.69%
Arbitrum $0.91 -3.80%
Solana $236.01 -1.90%
Polygon $0.56 -2.46%
Cosmos $8.21 -0.29%
Avalanche $42.39 -2.83%

LifeMine Therapeutics

company

Funding Round

Series C

Money Raised

$ 175M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
ARCH Venture Partners	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 18, 2017	Series A	$ 70M	Merck,ARCH Venture Partners	Detail
Jan 7, 2021	Series B	$ 50M	ARCH Venture Partners	Detail